These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15272621)

  • 21. Normalization of creatine kinase level during pregnancy in idiopathic hyperCKemia.
    Fukutake T; Hattori T
    Clin Neurol Neurosurg; 2001 Oct; 103(3):168-70. PubMed ID: 11532557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Creatine kinase and its MB isoenzyme in the third trimester and the peripartum period.
    Leiserowitz GS; Evans AT; Samuels SJ; Omand K; Kost GJ
    J Reprod Med; 1992 Nov; 37(11):910-6. PubMed ID: 1460608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum creatine kinase isoenzymes in Duchenne muscular dystrophy determined by sensitive enzyme immunoassay methods.
    Mokuno K; Riku S; Sugimura K; Takahashi A; Kato K; Osugi S
    Muscle Nerve; 1987 Jun; 10(5):459-63. PubMed ID: 3302699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Enzyme diagnosis in progressive muscular dystrophies, especially in the Duchenne type].
    Pernice W; Beckmann R; Renner S; Wais U
    Klin Padiatr; 1989; 201(3):167-76. PubMed ID: 2739342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased creatine kinase activity in cultured Duchenne dystrophic muscle cells.
    Iannaccone ST; Nagy B; Samaha FJ
    J Child Neurol; 1987 Jan; 2(1):17-21. PubMed ID: 3624824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Possibility of prenatal diagnosis of progressive muscular dystrophy: evaluation of creatine kinase activity in serum and the capping of lymphocytes].
    Venturoli A; Sensi A; Baricordi R; Artioli A; Osti L; Mari R; Ferroni G; Lucci M
    Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1988-94. PubMed ID: 6608363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum creatine kinase and pyruvate kinase in Duchenne muscular dystrophy carrier detection.
    Percy ME; Chang LS; Murphy EG; Oss I; Verellen-Dumoulin C; Thompson MW
    Muscle Nerve; 1979; 2(5):329-39. PubMed ID: 492209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnosis and natural history of Duchenne muscular dystrophy].
    Desguerre I; Laugel V
    Arch Pediatr; 2015 Dec; 22(12 Suppl 1):12S24-30. PubMed ID: 26773582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prednisone therapy in Becker's muscular dystrophy.
    Johnsen SD
    J Child Neurol; 2001 Nov; 16(11):870-1. PubMed ID: 11732779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enigmatic conflict of clinical and molecular diagnosis in Duchenne/Becker muscular dystrophy.
    Dubowitz V
    Neuromuscul Disord; 2006 Dec; 16(12):865-6. PubMed ID: 17118656
    [No Abstract]   [Full Text] [Related]  

  • 31. [Critical evaluation of changes of serum CK after exertion in the identification of carriers of Duchenne's muscular dystrophy].
    Cordone G; Venzano V; Rossi G; Cavallero G; Minetti C
    Pediatr Med Chir; 1984; 6(6):819-22. PubMed ID: 6545595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subclinical Becker's muscular dystrophy presenting with severe heart failure.
    Yokota R; Shirotani M; Kouchi I; Hirai T; Uemori N; Ohta Y; Mitsui Y; Hattori R
    Intern Med; 2004 Mar; 43(3):204-8. PubMed ID: 15098601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duchenne muscular dystrophy: issues in expanding newborn screening.
    Kemper AR; Wake MA
    Curr Opin Pediatr; 2007 Dec; 19(6):700-4. PubMed ID: 18025940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and environmental components of serum creatine kinase (CK) and pyruvate kinase (PK) in normal twins: implication for genetic risks estimates in Duchenne muscular dystrophy carriers.
    Rapaport D; Colletto GM; Zatz M
    Am J Med Genet; 1988 Oct; 31(2):291-8. PubMed ID: 3232697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early symptoms of Duchenne muscular dystrophy--description of cases of an 18-month-old and an 8-year-old patient.
    Iwańczak F; Stawarski A; Potyrała M; Siedlecka-Dawidko J; Agrawal GS
    Med Sci Monit; 2000; 6(3):592-5. PubMed ID: 11208376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review of Duchenne muscular dystrophy (DMD) for the pediatricians in the community.
    Verma S; Anziska Y; Cracco J
    Clin Pediatr (Phila); 2010 Nov; 49(11):1011-7. PubMed ID: 20724320
    [No Abstract]   [Full Text] [Related]  

  • 37. Biomarkers and surrogate endpoints in Duchenne: meeting report.
    Aartsma-Rus A; Ferlini A; Vroom E
    Neuromuscul Disord; 2014 Aug; 24(8):743-5. PubMed ID: 24951452
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of early second trimester maternal serum creatine kinase isoenzyme BB as a marker of poor pregnancy outcome.
    Jenkins CB; Ghidini A; Spong CY; Eglinton GS; Pezzullo JC; Michejda M
    Fetal Diagn Ther; 1997; 12(6):356-9. PubMed ID: 9475367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of carrier detection of Duchenne muscular dystrophy using carbonic anhydrase III and creatine kinase.
    Heath R; Carter ND; Jeffery S; Edwards RJ; Watts DC; Watts RL
    Am J Med Genet; 1985 Jun; 21(2):291-6. PubMed ID: 3925781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Creatine-kinase and pyruvate-kinase activities in normal children: implications in Duchenne muscular dystrophy carrier detection.
    Passos MR; Gonzalez CH; Zatz M
    Am J Med Genet; 1985 Oct; 22(2):255-62. PubMed ID: 4050856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.